Search - tctmd.com

Displaying 121 - 140 of 795

Sort: Relevancy | Date

Opening Debate: Which Metallic DES Should Be on My Cath Lab Shelf? - Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Presentation TCT 2019

Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Presenter: David Kandzari

September 26, 2019

Opening Debate: Which Metallic DES Should Be on My Cath Lab Shelf? - Choose Whatever You Want! Most Contemporary DES Display Comparable Clinical Performance!

Presentation TCT 2019

Choose Whatever You Want! Most Contemporary DES Display Comparable Clinical Performance!

Presenter: Stephan Windecker

September 26, 2019

Presentation TCT 2019

Clinical Trial Snapshots: Top DES Randomized Trials of the Last 2 Years

Presenter: Mamas Mamas

September 26, 2019

Presentation TCT 2019

TCT 98: Five-Year Clinical Results of Full Metal Jacket With Drug-Eluting Stents for Coronary Chronic Total Occlusion

Presenter: Lei Song

September 25, 2019

Presentation TCT 2019

TCT 56: Impact of Neoatherosclerosis on clinical Outcomes after Repeat Revascularization of In-Stent Restenosis of 2nd Generation Drug-Eluting Stents

Presenter: Zhaoyang Chen

September 25, 2019

Presentation TCT 2019

TCT 47: Five-Year Clinical Outcomes From Randomized Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients With Coronary Artery Disease From ABSORB China Trial

Presenter: Run-Lin Gao

September 25, 2019

Presentation TCT 2019

A Comparison of Multiple Short Stents With Long Stents for Femoral Popliteal Lesions: Results of the LOCOMOTIVE Trial of VascuFlex System (From B. Braun)

Presenter: Thomas Zeller

September 25, 2019

Presentation TCT 2019

Is the Supera Interwoven Stent Better Than Other Stents and Open Endarterectomy for Common Femoral Lesions?

Presenter: Lawrence Garcia

September 25, 2019

Presentation TCT 2019

TCT 11: Everolimus-eluting Bioresorbable Scaffolds versus Drug-eluting Stents in Patients with Acute Myocardial Infarction – 2-Year Results of the Randomized ISAR-Absorb MI Trial

Presenter: Jens Wiebe

September 25, 2019

Presentation TCT 2019

TCT 42: Polymer-free Drug-coated vs. Bare-metal Coronary Stents in Patients Undergoing Non-cardiac Surgery A Subgroup Analysis of the LEADERS FREE Trial

Presenter: Abdelhakim Allali

September 25, 2019

Session I: RCIS Introductory Session — Cardiac Catheterization and PCI: Foundational Knowledge for the Cath Lab - Devices and Imaging for PCI (Wires, Balloons, Stents, FFR, Imaging)

Presentation TCT 2019

Devices and Imaging for PCI (Wires, Balloons, Stents, FFR, Imaging)

Presenter: Morton Kern

September 25, 2019

Presentation CHIP Seattle 2019

How to Treat Underdeployed Stents

Presenter: Jennifer A Tremmel

August 02, 2019

Presentation EuroPCR 2019

3-year clinical outcome following treatment with thin, very thin or ultrathin strut drug-eluting stents in small coronary vessels in BIO-RESORT

Presenter: Clemens von Birgelen

May 21, 2019

Presentation EuroPCR 2019

Drug-coated Balloons vs. Drug-eluting Stents for the Treatment of Small Coronary Artery Lesions: Angiographic Analysis from the Randomised BASKET-SMALL 2 Trial

Presenter: Raban Jeger

May 20, 2019

Presentation ARCH 2019

Update: Drug-Eluting Stents

Presenter: Jeffrey W. Moses

April 12, 2019

Presentation CIT 2019

A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease: Three-Year Results of NeoVas RCT

Presenter: Yaling Han

March 28, 2019

Presentation CIT 2019

DESSOLVE C: A Randomized Multi-Center Controlled Trial Comparing 2 Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients with Coronary Artery Disease

Presenter: Bin Wang, Yaling Han

March 28, 2019

Presentation CIT 2019

Could Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery Increase the Risk of Death?

Presenter: Sahil A. Parikh

March 28, 2019

Presentation SIF 2019

The Interventional Toolkit:Guides, Wires, Balloons, and Stents

Presenter: Douglas E. Drachman

March 27, 2019

Presentation JIM 2019

TALENT: Thin strut sirolimus-eluting stent in all comers population vs Everolimus-eluting stent

Presenter: Giuseppe Tarantini

February 14, 2019

Advertisement

Choose Carefully: The Best New Generation DES are Associated With Meaningful Improvements In Performance and Outcomes!

Choose Whatever You Want! Most Contemporary DES Display Comparable Clinical Performance!

Clinical Trial Snapshots: Top DES Randomized Trials of the Last 2 Years

TCT 98: Five-Year Clinical Results of Full Metal Jacket With Drug-Eluting Stents for Coronary Chronic Total Occlusion

TCT 56: Impact of Neoatherosclerosis on clinical Outcomes after Repeat Revascularization of In-Stent Restenosis of 2nd Generation Drug-Eluting Stents

TCT 47: Five-Year Clinical Outcomes From Randomized Comparison of Everolimus-Eluting Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Metallic Stents in Patients With Coronary Artery Disease From ABSORB China Trial

A Comparison of Multiple Short Stents With Long Stents for Femoral Popliteal Lesions: Results of the LOCOMOTIVE Trial of VascuFlex System (From B. Braun)

Is the Supera Interwoven Stent Better Than Other Stents and Open Endarterectomy for Common Femoral Lesions?

TCT 11: Everolimus-eluting Bioresorbable Scaffolds versus Drug-eluting Stents in Patients with Acute Myocardial Infarction – 2-Year Results of the Randomized ISAR-Absorb MI Trial

TCT 42: Polymer-free Drug-coated vs. Bare-metal Coronary Stents in Patients Undergoing Non-cardiac Surgery A Subgroup Analysis of the LEADERS FREE Trial

Devices and Imaging for PCI (Wires, Balloons, Stents, FFR, Imaging)

How to Treat Underdeployed Stents

3-year clinical outcome following treatment with thin, very thin or ultrathin strut drug-eluting stents in small coronary vessels in BIO-RESORT

Drug-coated Balloons vs. Drug-eluting Stents for the Treatment of Small Coronary Artery Lesions: Angiographic Analysis from the Randomised BASKET-SMALL 2 Trial

Update: Drug-Eluting Stents

A Randomized Trial Comparing a Novel Sirolimus-Eluting Bioresorbable Scaffold with Everolimus-Eluting Metallic Stent in Patients with Coronary Artery Disease: Three-Year Results of NeoVas RCT

DESSOLVE C: A Randomized Multi-Center Controlled Trial Comparing 2 Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients with Coronary Artery Disease

Could Application of Paclitaxel-Coated Balloons and Stents in the Femoropopliteal Artery Increase the Risk of Death?

The Interventional Toolkit:Guides, Wires, Balloons, and Stents

TALENT: Thin strut sirolimus-eluting stent in all comers population vs Everolimus-eluting stent

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content